GlassScriptPhysician profile
Margaret Neiheisel
NPI 1073627741
$520.69
in general payments reported to CMS, 2019-2025
9 companies · $226 in 2025
The $226 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.82 · 2022: $41.07 · 2023: $75.70 · 2024: $156 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $457.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $135.77 | 2025 | Zoryve |
| Supernus Pharmaceuticals, INC. | $123.90 | 2021-2024 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $56.69 | 2024 | |
| Sanofi Pasteur INC. | $52.53 | 2022-2023 | |
| Organon LLC | $47.10 | 2025 | |
| Merck Sharp & Dohme LLC | $32.55 | 2023-2025 | Vaxelis, Vaxneuvance, Rotateq |
| Alk-Abello, INC | $28.91 | 2025 | Neffy |
| Pfizer INC. | $23.97 | 2024 | |
| Verrica Pharmaceuticals INC. | $19.27 | 2024 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Neiheisel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.